Vertex Pharmaceuticals Incorporated (FRA:VX1)
Germany · Delayed Price · Currency is EUR 396.15
-1.25 (-0.31%)
At close: Jan 30, 2026
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €100.35 billion as of January 30, 2026. Its market cap has decreased by -5.50% in one year.
Market Cap
100.35B
Enterprise Value
91.79B
Revenue
9.99B
Ranking
n/a
PE Ratio
32.04
Stock Price
€396.15
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 100.35B, an increase of 135,721.59%. That is a compound annual growth rate of 23.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 100.35B | 2.43% |
| Dec 31, 2025 | 97.97B | -2.20% |
| Dec 31, 2024 | 100.17B | 5.60% |
| Dec 29, 2023 | 94.86B | 36.76% |
| Dec 30, 2022 | 69.36B | 41.28% |
| Dec 31, 2021 | 49.09B | -2.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |